[Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus]

Jian-ping Wang, Chi Zhang, Jian Lin, Ying Yuan, Hai-feng Zhou, Gan Huang, Min Zhou, Zhi-guang Zhou
Zhonghua Yi Xue za Zhi [Chinese medical journal] 2007 September 11, 87 (34): 2380-4

OBJECTIVE: To explore the relationship between the 3 islet autoantibodies, i.e., glutamic acid decarboxylase antibody (GADA), protein-tyrosine-phosphatase-2 autoantibody (IA-2A), and insulin autoantibody (IAA), and human leukocyte HLA-DQ genotypes in the patients with type 1 diabetes mellitus (T1DM).

METHODS: Peripheral blood samples were collected from 495 T1DM patients and 376 healthy controls. Radioligand assay was used to detect the levels of GADA and IA-2A. Seventy-one of the 495 T1DM patients with insulin treatment less than 14 days underwent radioligand assay to measure the IAA level. 338 TIDM patients, including 187 antibodies-positive and 151 antibodies-negative patients, and 278 healthy controls underwent PCR and sequencing so as to examine the genetic polymorphism of HLA-DQ.

RESULTS: (1) The frequencies of DQA1*03-DQB1 *0303, DQA1*05-DQB1*0201, and DQA1*03-DQB1*0401 haplotypes in the T1DM patients were 32.6%, 14.1% and 10.2% respectively, all significantly higher than those in the controls (21.9%, 3.5%, and 2.9% respectively, all P < 0.01), however, the frequency of DQA1*0102-DQB1*0602 haplotype in the T1DM patients was 1.7%, significantly lower than that in the controls (5.3%, P < 0.05). (2) The GADA positive rates of in the T;DM patients with DQA1*05-DQB1*0201 or DQA1*03-DQB1*0401 haplotype were 55.8% and 65.5% respectively, both significantly higher than those of the T1DM patients without DQA1*05-DQB1*0201 or DQA1*03-DQB1*0401 haplotype (41.0% and 40.3%, respectively P < 0.05 or P < 0.01), and the IA-2A positive rate of the T1DM patients with DQA1*03-DQB1*0303 haplotype was 27.0%, significantly higher than that of the T1DM patients without DQA1*03-DQB1*0303 haplotype (7.9%, P < 0.01), there were no significant differences in GADA and IA-2A positivity between the T1DM patients with and without DQA1*03-DQB1*0302 haplotype (48.5% vs 43.9% and 24.2% vs 15.4%, both P > 0.05). The GADA positivity rate of the T1DM patients with DQA1*0102-DQB1 *0602 haplotype was 16.7%, significantly lower than those patients without DQA1*0102-DQB1 *0602 haplotype (45.9%, P < 0.05). There was no significant difference in IAA level between those patients with and without susceptible DQ alleles and haplotypes (P > 0.05).

CONCLUSION: GADA is associated with HLA-DQA1*05-DQB1*0201 and DQA1*03-DQB1*0401 haplotypes, and IA-2A is associated with DQA1*03-DQB1 *0303 haplotype.

Full Text Links

Find Full Text Links for this Article


You are not logged in. Sign Up or Log In to join the discussion.

Trending Papers

Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"